
Long-Term Overall Survival Analysis from A Randomized Phase II Trial Testing the Benefit of Stereotactic Body Radiotherapy Addition to Abiraterone Acetate in Oligometastatic Castrate Resistant Prostate Cancer Patients
Long-awaited survival data from the ARTO trial have confirmed that










